Marvin Edeas - Oysters and Peptides Derived from Hydrolysates Modulate Oxidative Stress
Using an oyster enzyme hydrolyzate within a composition that modulates oxidative stress and also gets rid of free radicals is what Marvin Edeas (Profil Marvin edeas - justia.com)' patents had to do with. As a result of these patents, a start-up was launched in order to market the peptide. Real uses have been discovered for the breakthroughs made by him. In Europe and the US, Marvin Edeas has filed two patents.
Marvin Edeas has written numerous books and publications. His research is regularly focused on in the specialised press. He examined the impacts of oxidative stress in HIV replication in asymptomatic and symptomatic HIV-infected patients in his thesis, defended in 1996. In 2015, Marvin Edeas wrote two reference works on the subject of mitochondrial medicine.
HIV - Important Research
The latency mechanisms of the HIV virus in patients who are HIV-positive, and the activation factors, is a field which he devoted six years to studying at the Antoine Béclère Hospital. Back in the nineties, Marvin Edeas conducted significant research on the acquired immunodeficiency virus. At Paris Descartes University, Marvin Edeas highlighted the impact of co-infections and oxidative stress in patients suffering HIV.
Marvin Edeas obtained his doctorate on HIV infections in symptomless patients in the year 1998 from Antoine Béclère Hospital. At the Paris-Descartes University, he followed a course on infectious diseases. Marvin Edeas worked in the Pulmonary Diseases Department at Armand Trousseau Hospital during the early nineties.
Marvin Edeas is chair of the French Society of Antioxidants. He, the SFA and ISANH strive to transfer basic research to real-world applications whether clinical, pharmaceutical, nutritional or cosmetic. He is Chair of the ISANH (International Society of Antioxidants in Nutrition & Health), founded in the year 1998 by Marvin Edeas.